EUROPEAN HEART JOURNAL, cilt.39, sa.6, ss.464-473, 2018 (SCI-Expanded)
Aims Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still used is largely unknown.